Molnupiravir N-1 CAS 2346620-55-9 COVID-19 Kualitas Luhur
Pasokan Komérsial Molnupiravir sareng Panganteur Patali sareng Kualitas Luhur
Uridine CAS 58-96-8
Cytidine CAS 65-46-3
Molnupiravir N-1 CAS 2346620-55-9
Molnupiravir (EIDD-2801) CAS 2349386-89-4
| Ngaran Kimia | Molnupiravir N-1 |
| sinonim | ((3aR,4R,6R,6aR)-6-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3, 4-d][1,3]dioxol-4-yl)métil isobutirat;Molnupiravir panengah;Molnupiravir Dimétil Dioxol Impurity;Kotoran Molnupiravir 11 |
| Nomer CAS | 2346620-55-9 |
| Nomer CAT | RF-PI310 |
| Status saham | Dina Stok, Skala Produksi Nepi ka Ratusan Kilogram |
| Formula Molekul | C16H23N3O7 |
| Beurat Molekul | 369.37 |
| Kalarutan | Leyur dina DMSO |
| Kapadetan | 1,51±0,1 g/cm3 |
| Suhu Pangiriman | Ambient |
| merek | Kimia Ruifu |
| Barang | spésifikasi |
| Penampilan | Bodas ka Pareum-Bodas Bubuk |
| Leungitna dina Drying | ≤1,0% |
| Résidu on Ignition | ≤0,20% |
| Najis Tunggal | ≤0,50% |
| Total Kotoran | ≤2,0% |
| Logam beurat | ≤20ppm |
| Kasucian | ≥98,0% |
| Standar tés | Standar Perusahaan |
| Pamakéan | Panganteur Molnupiravir (CAS 2349386-89-4) COVID-19 |
Bungkusan: Botol, kantong Aluminium foil, kardus drum, 25kg / Drum, atawa nurutkeun sarat customer urang.
Kaayaan Panyimpenan:Simpen dina wadah anu disegel dina tempat anu tiis sareng garing;Ngajaga tina cahaya, Uap jeung infestation hama.
Molnupiravir N-1 (CAS 2346620-55-9), mangrupikeun perantara Molnupiravir (CAS 2349386-89-4) dina pengobatan COVID-19.Molnupiravir (EIDD-2801) mangrupikeun bentuk bioavailable sacara lisan tina analog ribonucleoside anu pohara kuat anu ngahambat réplikasi sababaraha virus RNA kalebet SARS-CoV-2, agén sabab COVID-19.EIDD-2801 (7 mg/kg; po; dua kali sapoé salila 3,5 poé) nyata ngurangan beban virus héd jeung lilana muriang.Molnupiravir (EIDD-2801) éfisién dihidrolisis dina vivo saatos diserep, hasilna ngan ukur NHC bébas dina plasma.EIDD-2801 sacara kuat ngirangan titer inféksi MERS-CoV, RNA virus, sareng patogenesis dina kaayaan terapi prophylactic sareng awal.Molnupiravir (EIDD-2801, MK-4482) mangrupikeun prodrug bioavailable oral tina analog ribonucleoside β-d-N4-hydroxycytidine (NHC; EIDD-1931) kalayan kagiatan antiviral spéktrum lega ngalawan SARS-CoV-2, MERS-CoV, SARS-CoV, sareng agén sabab COVID-19.
